Farquhar Cynthia M, Li Zhuoyang, Lensen Sarah, McLintock Claire, Pollock Wendy, Peek Michael J, Ellwood David, Knight Marian, Homer Caroline Se, Vaughan Geraldine, Wang Alex, Sullivan Elizabeth
Department of Obstetrics and Gynaecology, University of Auckland, Auckland, New Zealand.
Australian Centre for Public and Population Health Research, Faculty of Health, University of Technology Sydney, Sydney, New South Wales, Australia.
BMJ Open. 2017 Oct 5;7(10):e017713. doi: 10.1136/bmjopen-2017-017713.
Estimate the incidence of placenta accreta and describe risk factors, clinical practice and perinatal outcomes.
Case-control study.
Sites in Australia and New Zealand with at least 50 births per year.
Cases were women giving birth (≥20 weeks or fetus ≥400 g) who were diagnosed with placenta accreta by antenatal imaging, at operation or by pathology specimens between 2010 and 2012. Controls were two births immediately prior to a case. A total of 295 cases were included and 570 controls.
Data were collected using the Australasian Maternity Outcomes Surveillance System.
Incidence, risk factors (eg, prior caesarean section (CS), maternal age) and clinical outcomes of placenta accreta (eg CS, hysterectomy and death).
The incidence of placenta accreta was 44.2/100 000 women giving birth (95% CI 39.4 to 49.5); however, this may overestimated due to the case definition used. In primiparous women, an increased odds of placenta accreta was observed in older women (adjusted OR (AOR) women≥40 vs <30: 19.1, 95% CI 4.6 to 80.3) and current multiple birth (AOR: 6.1, 95% CI 1.1 to 34.1). In multiparous women, independent risk factors were prior CS (AOR ≥2 prior sections vs 0: 13.8, 95% CI 7.4 to 26.1) and current placenta praevia (AOR: 36.3, 95% CI 14.0 to 93.7). There were two maternal deaths (case fatality rate 0.7%).Women with placenta accreta were more likely to have a caesarean section (AOR: 4.6, 95% CI 2.7 to 7.6) to be admitted to the intensive care unit (ICU)/high dependency unit (AOR: 46.1, 95% CI 22.3 to 95.4) and to have a hysterectomy (AOR: 209.0, 95% CI 19.9 to 875.0). Babies born to women with placenta accreta were more likely to be preterm, be admitted to neonatal ICU and require resuscitation.
评估胎盘植入的发生率,并描述其危险因素、临床实践及围产期结局。
病例对照研究。
澳大利亚和新西兰每年分娩量至少为50例的场所。
病例为2010年至2012年间经产前影像学检查、手术或病理标本诊断为胎盘植入的分娩女性(孕周≥20周或胎儿体重≥400克)。对照为病例之前紧邻的两次分娩。共纳入295例病例和570例对照。
使用澳大利亚产妇结局监测系统收集数据。
胎盘植入的发生率、危险因素(如既往剖宫产、产妇年龄)及临床结局(如剖宫产、子宫切除术和死亡)。
胎盘植入的发生率为每10万例分娩女性中有44.2例(95%置信区间39.4至49.5);然而,由于所使用的病例定义,这一发生率可能被高估。在初产妇中,年龄较大的女性(年龄≥40岁与<30岁相比的调整比值比[AOR]:19.1,95%置信区间4.6至80.3)和当前多胎妊娠(AOR:6.1,95%置信区间1.1至34.1)发生胎盘植入的几率增加。在经产妇中,独立危险因素为既往剖宫产(既往剖宫产≥2次与0次相比的AOR:13.8,95%置信区间7.4至26.1)和当前前置胎盘(AOR:36.3,95%置信区间14.0至93.7)。有2例产妇死亡(病死率0.7%)。胎盘植入的女性更有可能接受剖宫产(AOR:4.6,95%置信区间2.7至7.6)、入住重症监护病房/高依赖病房(AOR:46.1,95%置信区间22.3至95.4)以及接受子宫切除术(AOR:209.0,95%置信区间19.9至875.0)。胎盘植入女性所生婴儿更有可能早产、入住新生儿重症监护病房并需要复苏。